Comparison of Peritonsillar Infiltration of Tramadol Ketamine and Placebo on Pediatric Posttonsillectomy Pain
Sleep Disorder; Breathing-Related, Pain, Postoperative, Child, Only
About this trial
This is an interventional treatment trial for Sleep Disorder; Breathing-Related focused on measuring Adenotonsillectomy, pain, topic analgesia, child
Eligibility Criteria
Inclusion Criteria:
- Sleep disordered breathing
- ASA I-II
Exclusion Criteria:
- ASA III-IV physical status
- Coagulation disturbances
- Presence of relevant drug allergies
- pulmonary and cardiac diseases
- Craniofacial anomalies
- Mental diseases
- Genetic disorders
- Peritonsillar abscess formation
- Regular use of analgesics 24 h prior to surgery
Sites / Locations
- Juliana Alves de Sousa Caixeta
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
tramadol
ketamine
Placebo
Tramadol group will receive 2 mg/kg (2 ml) through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. The depth of the infiltration will be as superficial as 3 mm of needle injected and ballooned out the submucosal tissues of the tonsillar pillar, intratonsillar injection as avoided.
Ketamine group will receive 0.5 mg/kg (2cc) through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. The depth of the infiltration will be as superficial as 3 mm of needle injected and ballooned out the submucosal tissues of the tonsillar pillar, intratonsillar injection as avoided.
Placebo group will receive 2mL of saline solution through the peritonsillar fossa. For each tonsil 1 ml will be applied to upper pole, lower pole and between the upper and lower pole with 25-G needle. The depth of the infiltration will be as superficial as 3 mm of needle injected and ballooned out the submucosal tissues of the tonsillar pillar, intratonsillar injection as avoided.